Page 11 - B Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Pfizer Today - Breaking & Trending Today

Pfizer: COVID-19 pills were 89% against hospitalization, death; fought back omicron in lab studies

A Pfizer pill for COVID-19 reduced the risk of hospitalization or death by 89% compared to a placebo group, the company said Tuesday in final study results that are similar to initial findings. Pfizer also said its drug, Paxlovid, showed "robust antiviral activity" against the omicron variant in lab studies. ....

Albert Bourla , Drug Administration , B Health Medical Pharma , B Pfizer ,

Pfizer jabs protect 70% against hospitalization from omicron

A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday. ....

South Africa , United States , Johns Hopkins University , Network For Genomic Surveillance , Washington Times , Discovery Health , African Medical Research Council , South African Medical Research , Johns Hopkins , Genomic Surveillance , Ryan Noach , B Health Medical Pharma , South Africa , B Pfizer ,

Pfizer: COVID-19 pills were 89% against hospitalization, death; fought back omicron in lab studies

A Pfizer pill for COVID-19 reduced the risk of hospitalization or death by 89% compared to a placebo group, the company said Tuesday in final study results that are similar to initial findings. Pfizer also said its drug, Paxlovid, showed "robust antiviral activity" against the omicron variant in lab studies. ....

Albert Bourla , Drug Administration , B Health Medical Pharma , B Pfizer ,

FDA expands Pfizer COVID booster, opens extra dose to age 16

The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's vaccine. ....

United States , Centers For Disease , Washington Times , Drug Administration , Disease Control , B Health Medical Pharma , B Pfizer , B Biontech ,

FDA expands Pfizer COVID booster, opens extra dose to age 16

The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's vaccine. ....

United States , Centers For Disease , Washington Times , Drug Administration , Disease Control , B Health Medical Pharma , B Pfizer , B Biontech ,